The Impact of the Ketogenic Diet on Glial Cells Morphology. A Quantitative Morphological Analysis

Neuroscience ◽  
2019 ◽  
Vol 413 ◽  
pp. 239-251 ◽  
Author(s):  
K. Gzielo ◽  
Z. Soltys ◽  
Z. Rajfur ◽  
Z.K. Setkowicz
2021 ◽  
pp. 0021955X2110137
Author(s):  
Yao Dou ◽  
Denis Rodrigue

In this study, foamed recycled high density polyethylene (rHDPE) parts were produced by rotational molding using different concentration (0 to 1% wt.) of a chemical blowing agent (CBA) based on azodicarbonamide. From the samples produced, a complete morphological, thermal and mechanical characterization was performed. The morphological analysis showed a gradual increase in the average cell size, while the cell density firstly increased and then decreased with increasing CBA content. As expected, increasing the CBA content decreased the foam density as well as the thermal conductivity. Although increasing the CBA content decreased both tensile and flexural properties, the impact strength showed a similar trend as the cell density with an optimum CBA content around 0.1% wt. Finally, neat rHDPE samples were also produced by compression molding. The results showed negligible differences between the rotomolded and compression molded properties indicating that optimal rotomolding conditions were selected. These results confirm the possibility of using 100% recycled polymers to produce rotomolded foam parts.


2020 ◽  
Vol 22 (Supplement_3) ◽  
pp. iii291-iii292
Author(s):  
Alexandre Perez ◽  
Janak Nathan ◽  
Moatasem El-Ayadi ◽  
Christian Korff ◽  
Marc Ansari ◽  
...  

Abstract PURPOSE Diffuse Intrinsic Pontine Glioma (DIPG) is one of the most devastating diseases amongst children with cancer, thus novel strategies are urgently needed. We aimed to retrospectively evaluate the feasibility of the carbohydrate restricted ketogenic diet (KD) in DIPG patients. METHODS Searches of MEDLINE and Embase identified four publications meeting the inclusion criteria (diagnosis of DIPG and exposition to a KD ≥ 3 months). One additional case was identified by contact with experts. The minimal feasibility criteria were defined as the ability to use the KD for ≥ 3 months. Individual patient data were extracted from the publications or obtained from investigators. RESULTS Five patients (males, n=3; median age 4.4 years; range, 2.5–17 years) met the inclusion criteria (one patient – identified and not included - was on KD < 3 months due to disease progression). Further feasibility analyses showed a duration of the KD of ≥ 3 months and less than 7 months (n=2), > 7 months and less than 1 year (n= 2), and two years (n=1), respectively. CONCLUSION These results – based on a small patient population – suggest that the KD appears to be a feasible treatment option for children with DIPG. The potential duration of the KD is limited by the aggressive clinical behavior of DIPG. The safety analysis is currently being retrospectively assessed. These data should encourage further studies on a larger scale; ideally assessing the impact of the KD in DIPG patients in a randomized controlled trial.


2013 ◽  
Vol 304 ◽  
pp. 111-127 ◽  
Author(s):  
Jeremy R. Corfield ◽  
Justin M. Krilow ◽  
Maureen N. Vande Ligt ◽  
Andrew N. Iwaniuk

2007 ◽  
Vol 51 (3-4) ◽  
pp. 85-90 ◽  
Author(s):  
C. Y. Wang ◽  
P. J. Bates ◽  
M. Aghamirian ◽  
G. Zak ◽  
R. Nicholls ◽  
...  

10.2196/19053 ◽  
2020 ◽  
Vol 9 (8) ◽  
pp. e19053
Author(s):  
Sean R Locke ◽  
Kaja Falkenhain ◽  
Dylan A Lowe ◽  
Terry Lee ◽  
Joel Singer ◽  
...  

Background Obesity and being overweight are major contributing factors for many diseases. Calorie restricted diets often fail to result in sustained long-term weight loss. Very low–carbohydrate, high-fat ketogenic diets have been suggested to have superior metabolic and weight loss effects. Keyto is a low-cost, highly scalable mobile health (mHealth) app paired with a noninvasive biofeedback tool aimed at facilitating weight loss through a personalized healthy and predominantly plant- and fish-based ketogenic diet. Objective This protocol describes a randomized trial comparing the efficacy of the Keyto mHealth app and device intervention to that of Weight Watchers’ WW app in individuals who are overweight or obese. The primary outcome is weight loss after 12 weeks. Secondary and exploratory outcomes, including metabolic and cardiovascular risk factors, will be assessed at 12, 24, and 48 weeks. Methods A total of 144 participants will be recruited and randomized to either the Keyto program or Weight Watchers program. Study participants will be guided through the study via video conference or phone calls and will undergo a fasting blood analysis performed by a third-party diagnostic lab at weeks 0 and 12 to assess metabolic and cardiovascular risk markers. All participants will be asked to weigh themselves daily on a study-provided Bluetooth-enabled scale. Participants randomized to the Keyto arm will also be asked to measure their breath acetone levels, a measure of ketosis, with the Keyto device 3 times per day. Results Recruitment started in December 2019. Rolling recruitment is expected to be completed by July 2020. Data collection and analysis of the primary intervention phase is expected to be completed in October 2020. The 24- and 48-week follow-ups are expected to be completed in January 2021 and July 2021, respectively. Conclusions This trial will provide high-quality evidence regarding the efficacy of the Keyto weight loss program in individuals who are overweight and obese in a free-living condition. This study also fills a gap by examining the impact of a ketogenic diet emphasizing plant- and fish-based fats on blood lipid profile and cardiovascular disease risk. Trial Registration ClinicalTrials.gov NCT04165707; https://clinicaltrials.gov/ct2/show/NCT04165707. International Registered Report Identifier (IRRID) DERR1-10.2196/19053


Development ◽  
2016 ◽  
Vol 143 (6) ◽  
pp. 1029-1040 ◽  
Author(s):  
Xuejun Chai ◽  
Shanting Zhao ◽  
Li Fan ◽  
Wei Zhang ◽  
Xi Lu ◽  
...  

2000 ◽  
Vol 45 (12) ◽  
pp. 1073-1081 ◽  
Author(s):  
Sylvie Séguier ◽  
Gaston Godeau ◽  
Michelle Leborgne ◽  
Gérard Pivert ◽  
Nicole Brousse

Sign in / Sign up

Export Citation Format

Share Document